Basic Information
| RNALocate ID: | RLID:11003525 |
| RNA Symbol: | hsa-miR-769-5p |
| Localization: | Microvesicle |
RNA Information
| RNA Name: | hsa-miR-769-5p |
| RNA ID: | miRBase:MIMAT0003886 |
| RNA Category: | miRNA |
| Species: | Homo sapiens |
Localization Information
| PubMed ID: | 24797360 |
| Tissue/Cell Line: | Cerebrospinal fluid |
| Method: | RNA sequencing |
| Description: | Differentially expressed miRNAs detected in the cerebrospinal fluid (CSF). Data are collected from Table 1. |
Other Subcellular Localization
| RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
| RLID:01002543 | Mitochondrion | Skeletal muscle myoblasts | 21637849 |
| RLID:11003521 | Exosome | B cell line (Raji)|Primary dendritic cells|T cell line (J77) | 21505438 |
| RLID:11003522 | Exosome | Plasma | 23663360 |
| RLID:11003523 | Microvesicle | Seminal plasma | 23539611 |
| RLID:11003524 | Microvesicle | Follicular fluid | 23666971 |
| RLID-D:11000175 | Exosome | B lymphoblastoid cells|Endothelial cells|Lymphoma tissue|Mast cells|Tongue tissue | |
| RLID-D:11000560 | Microvesicle | Colon cancer cell line (LIM1863)|Fibroblasts|Mesenchymal stem cells|Urine |
ncRNA Disease Information
| Resource | RNA Symbol | Disease | Link |
| MNDR | hsa-miR-769-5p | High-grade serous ovarian carcinoma | MNDR-E-MI-69329 |
| MNDR | hsa-miR-769-5p | Uterine corpus endometrial carcinoma | MNDR-E-MI-69330 |
| MNDR | hsa-miR-769-5p | Lymphoma | MNDR-E-MI-69331 |
| MNDR | hsa-miR-769-5p | Estrogen-receptor positive breast cancer | MNDR-E-MI-69332 |
| MNDR | hsa-miR-769-5p | Estrogen-receptor negative breast cancer | MNDR-E-MI-69333 |
| MNDR | hsa-miR-769-5p | Progesterone-receptor positive breast cancer | MNDR-E-MI-69334 |
| MNDR | hsa-miR-769-5p | Progesterone-receptor negative breast cancer | MNDR-E-MI-69335 |
| MNDR | hsa-miR-769-5p | Breast cancer luminal | MNDR-E-MI-69336 |
| MNDR | hsa-miR-769-5p | Prostate cancer | MNDR-E-MI-69337 |
| MNDR | hsa-miR-769-5p | Gastric cancer | MNDR-E-MI-69338 |
| MNDR | hsa-miR-769-5p | Alzheimer disease | MNDR-E-MI-69339 |
| MNDR | hsa-miR-769-5p | Intracranial aneurysm | MNDR-E-MI-69340 |
| MNDR | hsa-miR-769-5p | Head and neck cancer | MNDR-E-MI-69341 |
| MNDR | hsa-miR-769-5p | Leukemia | MNDR-E-MI-69342 |
| MNDR | hsa-miR-769-5p | Cardiovascular disease | MNDR-E-MI-69343 |
| MNDR | hsa-miR-769-5p | Lung cancer | MNDR-E-MI-69344 |
| MNDR | hsa-miR-769-5p | Parkinson disease | MNDR-E-MI-69345 |
| MNDR | hsa-miR-769-5p | Breast cancer | MNDR-E-MI-69346 |
| MNDR | hsa-miR-769-5p | Pituitary neoplasms | MNDR-E-MI-69347 |
| MNDR | hsa-miR-769-5p | Pancreatic cancer | MNDR-E-MI-69348 |
| MNDR | hsa-miR-769-5p | Rectum adenocarcinoma | MNDR-E-MI-69349 |
| MNDR | hsa-miR-769-5p | Colon cancer | MNDR-E-MI-69350 |
| MNDR | hsa-miR-769-5p | Colon adenocarcinoma | MNDR-E-MI-69351 |
| MNDR | hsa-miR-769-5p | Multiple sclerosis relapsing-remitting | MNDR-E-MI-69352 |
| MNDR | hsa-miR-769-5p | Ovarian cancer | MNDR-E-MI-69353 |
| MNDR | hsa-miR-769-5p | Acromegaly | MNDR-E-MI-69354 |
| MNDR | hsa-miR-769-5p | Carcinoma ductal breast | MNDR-E-MI-69355 |
| MNDR | hsa-miR-769-5p | Malignant glioma | MNDR-E-MI-69356 |
| MNDR | hsa-miR-769-5p | Osteosarcoma | MNDR-E-MI-69357 |
| MNDR | hsa-miR-769-5p | Pituitary adenoma | MNDR-E-MI-69358 |
| MNDR | hsa-miR-769-5p | Lung squamous cell carcinoma | MNDR-E-MI-69359 |
| MNDR | hsa-miR-769-5p | Non-small cell lung cancer | MNDR-E-MI-69360 |
| MNDR | hsa-miR-769-5p | Lung adenocarcinoma | MNDR-E-MI-69361 |
| MNDR | hsa-miR-769-5p | Adrenocortical cancer | MNDR-E-MI-69362 |
| MNDR | hsa-miR-769-5p | Thyroid carcinoma | MNDR-E-MI-69363 |
| MNDR | hsa-miR-769-5p | Ovarian carcinoma | MNDR-E-MI-69364 |
| MNDR | hsa-miR-769-5p | Pancreatic adenocarcinoma | MNDR-E-MI-69365 |
| MNDR | hsa-miR-769-5p | Carcinoma renal cell | MNDR-E-MI-69366 |
| MNDR | hsa-miR-769-5p | Kidney renal papillary cell carcinoma | MNDR-E-MI-69367 |
| MNDR | hsa-miR-769-5p | Renal clear cell carcinoma | MNDR-E-MI-69368 |
| MNDR | hsa-miR-769-5p | Cholangiocarcinoma | MNDR-E-MI-69369 |
| MNDR | hsa-miR-769-5p | Liver cirrhosis | MNDR-E-MI-69370 |
| MNDR | hsa-miR-769-5p | Lung small cell carcinoma | MNDR-E-MI-69371 |
| MNDR | hsa-miR-769-5p | Synovial sarcoma | MNDR-E-MI-69372 |
| MNDR | hsa-miR-769-5p | Head and neck squamous cell carcinoma | MNDR-E-MI-69373 |
| MNDR | hsa-miR-769-5p | Growth hormone-secreting pituitary adenoma | MNDR-E-MI-69374 |
| MNDR | hsa-miR-769-5p | Adenoma | MNDR-E-MI-69375 |
| MNDR | hsa-miR-769-5p | Breast invasive carcinoma | MNDR-E-MI-69376 |
| MNDR | hsa-miR-769-5p | Hepatocellular carcinoma | MNDR-E-MI-69377 |
| MNDR | hsa-miR-769-5p | Rheumatoid arthritis | MNDR-E-MI-69378 |
| MNDR | hsa-miR-769-5p | Hodgkin lymphoma | MNDR-E-MI-69379 |
| MNDR | hsa-miR-769-5p | Skin cutaneous melanoma | MNDR-E-MI-69380 |
| MNDR | hsa-miR-769-5p | Skin melanoma | MNDR-E-MI-69381 |
| MNDR | hsa-miR-769-5p | Acute myeloid leukemia | MNDR-E-MI-69382 |
| MNDR | hsa-miR-769-5p | Colorectal cancer | MNDR-E-MI-69383 |
RNA Interaction Information
| Resource | RNA Symbol | Species | Link | RNALocate ID |
| RNAInter | GSK3B | Homo sapiens | RR00644438 |
TOP